Articles related to MYOCARDITIS/PERICARDITIS
The 1-Minute Consult: Is Exercise Restriction Necessary in Patients with Pericarditis?
This review with case example explores pericarditis and myocarditis and implications on limiting exercise. The authors summarize relevant guidelines and provide their own conclusion and guidance. They offer a helpful algorithm combining the ESC, ACC, and AHA guidelines and suggest an additional element around limiting heart rate during an acute inflammatory episode.
Cardiology September 6th 2022
COVID-19 Vaccination–Associated Myocarditis in Adolescents
A new study published in Pediatrics concludes that there is a quick clinical recovery and excellent short-term outcomes for adolescents who develop COVID-19-related vaccination-associated myocarditis (C-VAM). The average age in the study was 15, and close follow-up and further studies are needed to understand the long-term implications and mechanism of these myocardial tissue changes.
Cardiology November 9th 2021
CDC Confirms 226 Cases of Myocarditis After COVID-19 Vaccination in People 30 and Under
The data was presented to the FDA, which reported 789 cases of myocarditis/pericarditis – predominantly in males – after receiving the Pfizer/BioNTech and Moderna vaccines, most commonly after the second dose. Symptoms included chest pain, elevated cardiac enzymes, ST or T wave changes, dyspnea, and abnormal echocardiography/imaging for those ages 30 years and younger.
Cardiology June 15th 2021
CDC Releases Guidance for Clinicians on Heart Inflammation After COVID-19 Vaccination
Since April 2021, there have been reports of myocarditis and/or pericarditis after receipt of an m-RNA COVID-19 vaccine, according to the Centers for Disease Control and Prevention (CDC) . Most cases have been among male adolescents and young adults ages 16 and older, typically occurring within several days after the second dose of m-RNA COVID-19 vaccine.
Cardiology June 2nd 2021